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Abstract
Summary Fracture risk assessments on bone mineral density
reports guide family physicians’ treatment decisions but are
subject to inaccuracy. Qualitative analysis of interviews with
22 family physicians illustrates their pervasive questioning of
reported assessment accuracy and independent assumption of
responsibility for assessment. Assumption of responsibility is
common despite duplicating specialists’ work.
Introduction Fracture risk is the basis for recommendations of
treatment for osteoporosis, but assessments on bone mineral
density (BMD) reports are subject to known inaccuracies.
This creates a complex situation for referring physicians,
who must rely on assessments to inform treatment decisions.
This study was designed to broadly understand physicians’
current experiences with and preferences for BMD reporting;
the present analysis focuses on their interpretation and use of
the fracture risk assessments on reports, specifically
Methods A qualitative, thematic analysis of one-on-one inter-
views with 22 family physicians in Ontario, Canada was
performed.
Results The first major theme identified in interview data
reflects questioning by family physicians of reported fracture
risk assessments’ accuracy. Several major subthemes related
to this included questioning of: 1) accuracy in raw bone
mineral density measures (e.g., g/cm2); 2) accurate inclusion
of modifying risk factors; and 3) the fracture risk assessment
methodology employed. A secondmajor theme identified was
family physicians’ independent assumption of responsibility
for risk assessment and its interpretation. Many participants
reported that they computed risk assessments in their practice
to ensure accuracy, even when provided with assessments on
reports.
Conclusions Results indicate family physicians question ac-
curacy of risk assessments on BMD reports and often assume
responsibility both for revising and relating assessments to
treatment recommendations. This assumption of responsibili-
ty is common despite the fact that it may duplicate the efforts
of reading physicians. Better capture of risk information on
BMD referrals, quality control standards for images and stan-
dardization of risk reporting may help attenuate some
inefficiency.
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Introduction
In recent years, assessment of fracture risk has emerged as the
basis for treatment recommendations for osteoporosis. The
2010 Osteoporosis Canada guidelines explicitly recommend
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that physicians who refer patients for a bone mineral density
(BMD) test make decisions about pharmacological therapy
based on risk [1]. Organizations like the International Society
for Clinical Densitometry (ISCD) [2] and the Canadian Asso-
ciation of Radiologists (CAR) [3] recommend that these risk
assessments appear, when they are applicable, on BMD
reports.
However, assessment of risk is nuanced for several reasons.
Most significantly, risk assessment depends on information
above and beyond raw BMD results [1]. Specialists who
generate BMD reports must attend to additional risk factors,
such as corticosteroid and fragility fracture history, in order to
ensure risk assessment accuracy [4]. These additional risk
factors, however, may not readily be available to reading
specialists, resulting in assessments that are based on incom-
plete information. As an example, in a 2008 survey of BMD
reports for individuals with a known history of fragility frac-
ture, more than 50 % of the reports made no mention of
previous fracture; reported risk assessments were
underestimated on these reports as a result [5]. A 2006 survey
of more than 700 clinician members of the ISCD found that
71 % had seen BMD reports with interpretation errors; 25 %
reported that they saw errors more than once a week [6].
In addition to their dependence on modifying clinical
factors, fracture risk assessments are complicated by the
fact that they can be computed using a variety of heuristics
from different clinical practice guidelines. A recent system-
atic review of fracture assessment methods identified 12
different externally validated fracture risk assessment tools
available for use [7]. The Canadian Association of Radiol-
ogists (CAR) has sanctioned the use of the Canadian Asso-
ciation of Radiologists and Osteoporosis Canada tool
(CAROC) for fracture risk assessment in the Canadian
population [8], but a commonly used and similarly sanc-
tioned alternative is the Canadian version of the FRAX
assessment tool [9].
An accurate risk assessment therefore requires reporting
clinician not only to accurately image bone but also to accu-
rately determine modifying clinical factors corresponding to
an assessment heuristic; these are independent of imaging
results. This makes BMD reporting a relatively time-
consuming process, as clinical factors must be both gathered
and verified by imaging facilities. Reimbursement for the time
to create BMD reports, however, has been increasingly scru-
tinized both in the US [10] and Canada [11]. While this
scrutiny has curbed rates of potentially unnecessary BMD
testing in Ontario [12], it may also be encouraging diagnostic
imaging facilities to limit the resources dedicated to the BMD
reporting process. Indeed, while detail-rich “consultative re-
ports” have been found to be both appreciated by reading
physicians and to positively influence care [13], they are
understood to be time-consuming to produce and are therefore
vulnerable to funding limitations.
The purpose of this study was to understand family physi-
cians’ current experiences with and preferences for BMD
reporting in Ontario, Canada [1]; the present analysis focuses
on their experiences receiving and interpreting the fracture
risk assessments on reports, specifically. In Ontario, Canada,
the majority of BMD tests are ordered by family physicians.
Materials and methods
Study design and overview
In order to identify BMD-reporting issues commonly encoun-
tered by referring physicians, a qualitative methodology was
used involving thematic analysis of data from one-on-one
interviews [14]. The purpose of the interviews was to yield
rich, but simple descriptions of problems and issues encoun-
tered so that recommendations for BMD referrals and reports
could be adjusted accordingly. While interviews covered a
broad range of topics related to reporting and referral, results
presented here focus on findings related to the interpretation
and use of fracture risk assessments, in particular. The
pragmatic nature of the work draws from qualitative de-
scription, which is a qualitative research approach known to
yield practical answers of relevance to policy makers and
health practitioners [15, 16].
Recruitment
Family physicians were recruited between November 2011
and June 2012 through an event on osteoporosis held by the
Ontario College of Family Physicians. Recruited physi-
cians were asked to identify additional physicians who
might be interested in participating; these additional physi-
cians were also approached to participate as the study
progressed [17]. Requirements for participation were that
the physicians be English-speaking, in active family prac-
tice in Ontario, and have a history of ordering and receiving
results of BMD tests for patients. Approval for the study
was obtained from the Research Ethics Board at Women’s
College Research Institute (Protocol Reference #2008-
0064-E).
Recruitment ceased when the researchers determined that
data saturation had been reached, which is the point when
successive interviews become repetitive and no new signifi-
cant responses or major themes were discussed [17].
Data collection
Interviews consisted of questions related to the following
topic areas: (1) ordering or referring for BMD exams; (2)
interpreting and utilizing BMD exam results; and (3) commu-
nicating results to patients. Probes for each topic area were
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developed to explore issues in depth and to verify inter-
viewers’ understanding of the information being collected.
The interview guide was pilot tested with both a family
physician and a researcher experienced in qualitative research
in osteoporosis (JS).
Two members of the research team (SM, LC) were
responsible for conducting interviews. All interviews
took place either in person or over the telephone. Each
lasted an average of 45 min, was digitally recorded, and
subsequently transcribed. All interviews closed with
questions designed to capture basic demographic infor-
mation of each participant including roster size and the
location of practice.
Data analysis
To summarize the data, an inductive thematic analysis of
transcripts was performed [18]. To do this, the researchers
periodically met to review incoming interview data and be-
come familiar with the themes of interviews as they were
being consolidated. Two of the researchers (SM, LC) labeled
or “coded” transcripts so as to highlight themes; the themes
were then clustered and clusters refined as analysis
progressed. To facilitate coding and reflection upon themes,
notes from interviews and transcripts were analyzed. NVivo 9
(QSR, Victoria, Australia), a qualitative data storage software




Twenty-two family physicians with practices located in
urban or suburban Ontario participated in interviews. Of
these, five were from the Ontario College of Family
Physicians’ event on osteoporosis, and the remainder
were identified by prior participants through iterative
sampling. The mean roster size of the physicians was
1,208, and participants reported seeing an average of four
BMD reports in a week.
Overview of findings
“Fracture risk” was identified early in the analysis as an
organizing theme bridging several clusters of codes and span-
ning many topic areas (i.e., referral, report interpretation, and
report communication). Under the umbrella of this theme, two
major subthemes were developed: (1) questioning by family
physicians of reported fracture risk assessments’ accuracy
and (2) family physicians’ independent assumption of respon-
sibility for risk assessment and its interpretation. Results that
illustrate these themes were organized by the lead author (SA)
and verified by some members of the research team (SA, SM,
LC, and SJ).
Questioning by family physicians of reported fracture risk
assessments’ accuracy
During interviews, the majority of family physicians indicated
that they questioned the accuracy of the risk assessments on
BMD reports. The specific manner in which the accuracy of
fracture risk assessments was questioned, however, varied
significantly. Three major subcategories were identified in
an effort to capture this variation; these reflected questioning
by family physicians of: (1) accuracy in raw bone mineral
density measures (e.g., g/cm2); (2) accurate inclusion of mod-
ifying risk factors; and (3) the fracture risk assessment meth-
odology employed.
Among physicians that questioned accuracy of raw bone
mineral density measures, some identified technical factors as
probable sources of error while others identified factors asso-
ciated with interpretation of images with artifacts. Accuracy
concerns related to technical factors were, in general, very
broadly described by participants and related either to anti-
quated or ill-maintained equipment. As an example, Partici-
pant #7 had several patients call a particular scanning facility
“dirty,” and added:
“…because it was a private [facility], I’m not really sure
how old the scanner was. I mean, if patients complain
the place isn’t clean, you kind of wonder about the
equipment.”
Participant #19 also questioned the accuracy of raw BMD
measures on reports, but implicated a probable source of error
to lie in the interface between the BMD scanning machine and
reports. This participant described scanning attachments to
reports to verify raw BMD data:
“I do skim the actual absolute numbers because some-
times… you know, we’re all human. Sometimes they
report [raw BMD]… incorrectly.”
Other participants, by contrast, identified compromising
issues related to the clinical interpretation of raw BMD
measures, particularly for patients with osteoarthritis or
manifest degenerative change in the spine. As Participant
#2 explained:
“I say ‘this patient has osteoarthritis, I don’t care what
the report tells me’…. [On the report] the bone density is
normal and people will say ‘but I’m normal!’ I say ‘no,
but you fractured so you’re not normal’. This is my
problem with bone density.”
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Rather than commenting on inaccuracy due to artifacts,
Participant #7 commented on inaccuracy due inappropriate
choices of regions of interest:
“Some facilities… do not report the femoral neck T-
score at all. They report total hip. If you don’t have your
eyes open and look carefully, you could use the wrong T-
score. I have to go through the subsequent pages and
find femoral neck…”
A more substantial number of participants, however, fo-
cused their questioning around reports’ inclusion of modify-
ing risk factor information. Participants pointed specifically to
the fact that age constraints, fracture history, treatment status,
or other clinical variables were often missing from the BMD
reports they received. Participant #18 explained:
“Sometimes they’re wrong…. I’ve seen people not put in
fractures [on reports] when I know that [the patient]
had them.”
Similarly, Participant #13 noted missing risk factors on
reports, as well as missing assessments on reports, where
fracture risk was applicable:
“Risk factors are not incorporated into reports consis-
tently…. If you look at the various reports, there are
some whereby they’re still reporting just the T-scores.”
Opinions regarding why and how modifying risk factors
might be incorrectly factored into assessments were various.
Three participants explained that, when patients are asked
about risk factors, the resulting information is generally low
in quality. As an example of this, Participant #6 described a
study in which a resident compared risk factors reported by
patients on patient questionnaires to clinical data stored in
patient charts:
“It was kind of interesting that even when you get
patients to fill [the questionnaires], a lot of times they’re
either incomplete or they’re actually not accurate.”
Several physicians, however, indicated that they felt spe-
cific clinicians played a role in inaccurate capture of modify-
ing patient risk factors. For example, a few family physicians
questioned technologists’ ability to gather accurate or relevant
information about modifying risk factors.
“It really depends on who’s taking the [patient] histo-
ry at the bone density reporting facility in terms of the
consistency of the information that you’re going to get
from the patient, because not all fractures are fragility
fractures. You need a… technologist educated around
fragility fractures and other risk factors.” (Partici-
pant #13)
Participant #18 also focused questioning around technolo-
gists’ ability to accurately collect patient information:
“[Technologists] don’t always have stuff about falls.
Sometimes they’re wrong…. you know, someone’s forgot-
ten they’ve had a fracture or they think they had a
fracture when they actually didn’t or something like that.
There’s a whole lot of different kinds of things that make
you just kind of wonder if they really know the person…
like, we probably know them better.”
Like Participant #18, many of the interviewed family phy-
sicians identified themselves as better sources of risk factor
information than the clinicians at scanning facilities. Partici-
pant #8, for example, posited that:
“[Reports] will have comments…. ‘this person just re-
cently had a fracture’, because they asked through the
history. But I know a little bit more.”
To address the information gap between the family physi-
cians and the radiologists, Participant #19 described modify-
ing the standard BMD requisitions in an effort to better com-
municate risk factors to reading radiologists:
“I provide whatever I think they need [on the requisi-
tion] instead of just circling high risk. My radiology
colleagues and friends, they often go like ‘yeah we are
blind’… because the radiologists don’t always have a
chance to see the patient.”
A relatively small number of participants, by contrast, felt
that modifying risk factor information assembled by BMD
scanning facilities might actually bemore trustworthy than the
same information, assembled by family doctors. The reasons
for this revolved around the hectic pace of family doctors’
offices as well as the relative level of unfamiliarity on the part
of many family physicians with relevant risk factors. As an
example, Participant #21 noted, “if the office is crazy then in
may be hard for us to look at all the risk factors.” Participant
#11 explained that older family doctors, in particular, may not
be familiar with all the modifying risk factors emphasized by
recent clinical guidelines [1]. This participant volunteered
that, upon returning to practice after a hiatus:
“I had a conversation with my residents and my medical
students about [recent guidelines] and… it wasn’t any-
thing new to them. It was relatively new to me. I think
people in my generation, the message isn’t getting out…
I’m going to have to look [the new guidelines] up a few
times [before] it’s going to be stuck in my brain.”
As illustrated above, questioning of reported risk accuracy
related to raw BMD measures or missing modifying factors
was extensively represented in the interview data. In addition,
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a relatively small but rich subcategory of questioning focused
on fracture risk assessment methodologies. This encapsulated
both questioning of the CAROC as a potentially incomplete or
excessively abbreviated assessment tool and questioning of
fracture risk assessments’ application to older patients with
multiple, complex conditions. As an example, two partici-
pants (#7 and #3) expressed a basic skepticism of the CAROC
assessment tool due to the fact that it incorporates a limited
number of modifying risk factors relative to competing as-
sessment tools, like the FRAX. As Participant #7 explained:
“The CAROC doesn’t incorporate the smoking or the
alcohol or the parental hip fracture or whatever. It only
incorporates glucocorticoids and a previous fracture….
They said it’s just as good [as the FRAX], but it’s not.”
Questioning of fracture assessment methodology also fo-
cused on assessment tools’ applicability to older, more “frag-
ile” individuals and those with multiple conditions. Examples
of this variety of questioning follow:
“My patient population is 75 plus. The amount of re-
search that goes into just baseline figuring out what the
prognosis is of someone at the age of 75, 80 or 85 is
nonexistent. They’re excluded from almost every ran-
domized controlled trial. So I’m not sure what business
we have of prognosticating 10-year risks on people over
the age of 80…. 10-year risks are ridiculous. Nobody
knows what’s going to happen 10 years down the line.”
(Participant #17)
“If the person is 85 and they’re likely not to live more
than a few years, maybe it doesn’t matter if the risk is
high over 10 years.” (Participant #15)
In summary, while questioning of the accuracy of the
components used to produce risk assessments (i.e. raw mea-
sures of BMD and information about modifying factors) was
pervasive, a small but vocal group of physicians also
questioned the basic methodology used to arrive at 10-year
fracture risk assessments. Some felt the CAROC, which is
commonly used by radiologists in Canada, to be incomplete or
inferior to the FRAX while others felt the 10-year horizon on
risk assessments to be inapplicable to their older patients, in
particular.
Family physicians’ independent assumption of responsibility
for risk assessment and its interpretation
Many family physicians also described independently taking
steps either to recompute reported assessments entirely or to
verify components of fracture risk. While only a few physi-
cians reported exhaustively recomputing fracture risk assess-
ments, a relatively large number reported verifying elements
like raw BMD measures or modifying factors. Others
described recomputing assessments using tools like the
FRAX, but only when practical constraints allowed.
As examples of physicians that regularly recomputed re-
ported fracture risks in their entirety, Participants #3 and #7
both described deriving FRAX assessments using reported
BMD. Participant #7, for example, reported scanning BMD
reports to find femoral neck T-scores and extracting these to
“put in [the] FRAX.”While Participant #7 acknowledged that
this practice added substantial time to the reporting process,
the participant strongly asserted the need for family physicians
to dedicate this additional time in order to ensure reporting
accuracy:
“[A fracture risk assessment] does take time to work
out; I’m not going to pretend it doesn’t. But… we need to
focus on the main priorities in medicine. When osteo-
porosis kills more people that so many other major
diseases like strokes and heart attacks and even breast
cancer, really there’s no excuse to say ‘I don’t have the
time to do a FRAX or a CAROC’.”
Similarly, Participant #3 described regularly calculating
FRAX assessments for patients using the BMD measures
contained in reports. This participant stressed recomputation
to be particularly important for patients labeled “at risk:”
“If [the report] is at moderate and also if it’s at high risk,
I would still want to confirm it’s at high risk by doing a
FRAX score…. I basically just go into it and do the
calculation when I’m presented with the BMD.”
Like Participant #7, Participant #3 noted that the practice of
recomputing assessments added time-consuming steps to the
task of report interpretation, explaining: “I have to put the
numbers in [to the FRAX calculator], get the calculation, print
it and then scan it into the EMR.”
Participant #13 also described recomputation of risk as a
routine:
“I don’t trust the actual summaries [on BMD reports]
anymore. I still look at the T-scores. I still use the
CAROC method for assessing risk.”
And like Participant #7, this participant emphasized the
need for family physicians to assume assessment responsibil-
ity despite practical constraints:
“I liken [10-year fracture risk assessment] to the Fra-
mingham Risk Assessment that we’ve been doing for
years. I don’t think anything of getting the cholesterol
back and then punching in the other risk factors… and
coming up with an assessment. Assessing 10-year frac-
ture risk is really no different than that. Rather than a
cholesterol value, you’ve for a T-score, you know.”
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Other physicians, by contrast, did not describe consis-
tently dedicating the time to completely recompute fracture
risk assessments. Rather, a substantial number reported
verifying components of reported risk assessments (gener-
ally modifying risk factors). For example, Participant #8
detailed the steps taken to ensure consistent inclusion of
risk factors on reports:
“What I am doing now and I find it very helpful is I copy
the 10-year risk factors, I throw them in the chart, and
then every time I plot them as well. The first time [a
patient gets a BMD] I’ll put all their risk factors, the
minor and the major. [I] tick [risk factors] off and see on
the next one… if it’s changed.”
Participants #5 and #10 similarly described consulting
charts after receiving a BMD exam to validate modifying risk
factors; as Participant #10 explained:
“I pull the chart. Sometimes I know the patient well
and I sort of say, ok, I don’t remember anything like
that… so I don’t bother looking. If I don’t know the
patient well I pull [the chart] and start looking
through it quickly, to make sure that there are no
fractures that I can find.”
Participants #14 and #20, by contrast, explained that they
would sometimes recalculate assessments, but relatively in-
frequently. As Participant #20 explained:
“I will plug things into the FRAX… but it takes a little
time, so I usually don’t.”
This same participant expressed mixed feelings about
assuming responsibility for risk assessment calculations,
explaining: “I should [do the FRAX] because I know it’s
there. I don’t know, there is no good reason why I’m not
using it.”
In total, more than half of the participants indicated that
they either recomputed reported risk assessments or took steps
to verify risk assessments in some fashion. Those that made it
a practice of routinely and exhaustively recomputing risk
assessments acknowledged the process to be time-
consuming, but most shared a feeling that dedication of the
time was a responsibility. Other participants reported less
time-consuming methods to verify components of assess-
ments or to gauge overall accuracy. The sense of personal
responsibility for ensuring assessment accuracy was less
forcefully expressed in this group.
Those physicians that routinely recomputed assessments
also tended to assume sole responsibility for arriving at treat-
ment recommendations. Several in the group, in fact, de-
scribed their ideal reports as devoid of treatment recommen-
dations. Examples follow:
“For me, ideally, one page is fine. It means less scan-
ning. Just the T-scores of the spine and the femoral neck
and that’s it because I do my own fracture risk anyway.”
(Participant # 7)
“The way the report is [right now], it doesn’t help me to
make the decision about treatment… [but] I’m not say-
ing it doesn’t help me. I need the T-score from it.”
(Participant #3)
Participant #3, however, acknowledged that treatment rec-
ommendations were theoretically useful on reports for “at-
risk” patients:
“What you should be sending me is ‘high risk should
mean a patient should be treated’… moderate risk, help
us out a bit, [say] ‘treat or don’t treat’, you know.”
Participants who described less exhaustive verification of
risk assessments rather than overt recomputation, by contrast,
expressed more mixed opinions as to the value of treatment
recommendations on reports. Participant #19, for example,
expressed appreciation for recommendations as follows:
“If they dictate a recommendation to start something
based on what they see, it’s great… whether it’s a re-
minder or because they read so much they know the
guidelines better or something. At least then it’s like a
checkmark for us, too, so it sort of helps share the care.”
Participant #18, however, who described validating risk
assessments, claimed that in treatment recommendations:
“… I see a lot of variations in what I think are really
basically the same clinical scenario and I get different
recommendations from two different people. So [the
recommendations] don’t really make sense to me.”
Similarly, Participant #5, who described consulting charts
to verifying risk, asked of reading radiologists:
“Don’t recommend anything to me. I’m the one who has
to make the judgment as to if a patient should be treated
and with what.”
In summary, participants that reported routinely
recomputing risk assessments in their entirety and as a routine
also described assuming responsibility for treatment recom-
mendations; many of these same individuals explained that
they relied on the BMD report for T-scores alone. Some,
however, added that treatment recommendations would
theoretically be of use on reports, particularly for patients
categorized as ‘at risk’. By contrast, most participants that
either verified parts of assessments or recomputed them only
on occasion were less dismissive of treatment recommenda-
tions. While a few claimed not to value treatment
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recommendations, others described responsibility for treat-
ment recommendations as shared between them and the read-
ing radiologist. Many in this latter group explained that they
would weigh radiologists’ treatment recommendations, even
while they sometimes questioned the accuracy of radiologists’
overall assessments.
Discussion
Questioning by family physicians of reported fracture risk
assessments’ accuracy
In the current qualitative study of family physicians,
questioning of fracture risk accuracy on reports was pervasive
with three underlying themes: questioning of raw BMD
measures/images, accurate inclusion of risk factors, and the
validity of specific fracture risk assessment tools.
Results here indicate substantial concern among family
physicians as to the raw image quality of bone mineral density
exams. This reflects the pervasive concern about BMD report
quality documented in a 2006 survey of ISCD members [6]
and the frequency of positioning errors, particularly at the
spine and hip [19]. The ISCD has, in fact, developed an
accreditation program for facilities that addresses several of
the imaging quality concerns addressed by participants here
[20, 21]. Other imaging modalities have benefited from ac-
creditation; the image quality of mammograms, for example,
has notably improved since the implementation of the Mam-
mography Quality Standards Act (MSRA) [22] and its re-
quirement for US-based mammography facilities to meet uni-
form standards. In Canada, similar improvements to mammo-
grams have been noted, due to factors that include improved
technology and related measures for quality control [23]. The
ISCD accreditation program for BMD exams, however, has
yet to penetrate Canada, and the ISCDWebsite lists fewer than
40 accredited imaging facilities in the US as of 2013 [24].
Results also indicate some family physicians lack confi-
dence that imaging artifacts, most notably those due to spinal
osteoarthritis or spine degeneration, are reliably addressed in
BMD reports. According to CAR’s Technical Standards for
BMD reporting, such artifacts should be clearly noted and
considered on BMD reports when and where they exist [3]. It
is not possible, however, given the data in this study, to
determine if consideration of artifacts was in fact lacking on
reports received and described by participants.
Questioning related to the accurate inclusion of modifying
factors reflects recent evidence suggesting factors like fracture
history [5] may not, in fact, reliably be captured on BMD
reports. Our results indicate many family physicians are inde-
pendently taking steps to ensure such factors are reliably
incorporated into reported fracture risk assessments. Not all
physicians in the study, however, felt that they could
confidently or reliably recall factors that modify risk. The
CAR 2010 Technical Standards for BMD indicate that the
“specific history employed in risk determination” should ap-
pear on BMD reports for all patients [3]; our results indicate
that an exhaustive list of relevant modifying factors may
additionally serve to remind physicians of factors that require
attention. An exhaustive list, moreover, may help physicians
better identify when and where the FRAX, as opposed to the
CAROC, has been used.
In addition, results indicate that the sources of modifying
risk factor information may influence family physicians’ ac-
ceptance of the accuracy of this information. Several
questioned information provided on patient questionnaires or
collected by technologists. Questioning of information pro-
vided on patient questionnaires is, in fact, well founded; in a
recent survey of more than 6,500 post-menopausal female
patients in the US, for example, almost 50 % of documented
spine fractures and 20 % of documented hip fractures were
missed in patient self-reports [25]. A potential solution to this
issue would be to provide modifying risk factor information
on referral forms. Participant #19, in fact, describedmodifying
existing referral forms to better communicate modifying fac-
tors to reading radiologists, as is detailed in the study results.
Explicit capture of clinical factors relevant to risk assessment
has, moreover, already become standard practice on the BMD
referral forms in the provinces of British Columbia [26], Nova
Scotia, and Manitoba. Whether information from referral
forms reliably propagates to reports, however, remains to be
determined.
Finally, results demonstrate that a small group of family
physicians are skeptical of the CAROC’s equivalence to the
FRAX assessment tool, particularly when applied to individ-
uals at the boundary of moderate and high risk. Indeed, when
the CAROC and FRAX were validated in two Canadian
cohorts, the discordance in risk classifications assigned by
either tool was found to be greater than 10 % [27]. Clearer
guidelines or physician education as to the significance of
such discrepancies and the corresponding clinical implications
may therefore be warranted.
Family physicians’ independent assumption of responsibility
for risk assessment and its interpretation
The most notable result in this study is that a significant
percentage of participants reported actively dedicating time
to recalculating or verifying fracture risk assessments on
BMD reports. The amount of time that was dedicated relat-
ed to their interest in treatment recommendations. Those
individuals that recalculated risk entirely also tended to
disregard radiologists’ treatment recommendations. Those
that verified components of assessments expressed relative-
ly mixed opinions about the utility of radiologists’ treat-
ment recommendations.
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Prior research has indicated referring physicians to be
strongly divided in their views of treatment recommendations
on BMD reports [28, 29]. In a study of referring physicians
performed by Binkley and Krueger [28], 20 % of participants
indicated that treatment recommendations were “not required”
or “definitely unnecessary” on BMD reports while 66 %
found them either “essential” or “useful.” In a similar survey
of physicians referring for a wide range of ultrasounds, 9 %
indicated “recommendations of further nonradiological inves-
tigation” not to be of use while 71 % expressed that they
valued these recommendations [29]. Results presented here,
however, suggest that questioning of the accuracy in reported
risk assessments may moderate physicians’ interest in the
treatment recommendations that follow.
More importantly, however, the present study suggests a
substantial inefficiency in the current BMD reporting process.
About a half of the participants explained that they were
dedicating some time to the reporting process, (e.g., to recal-
culate the 10-year fracture risk assessment). Some participants
additionally explained that they disregarded treatment recom-
mendations on reports, meaning any work performed by the
radiologist to produce an assessment and relate it to a recom-
mendation was lost. By contrast, other participants explained
that they spent time to check assessments yet still weighed
treatment recommendations on reports in their final decisions.
In essence, these individuals expressed a desire for the kind of
detail-rich, “consultative” BMD reports that have been dem-
onstrated to improve care but have also been found to be time-
consuming for specialists to produce [13]. These same partic-
ipants, however, contributed their own time to the reporting
process even in the presence of these consultative reports. In
many reporting scenarios, then, substantial duplication of
efforts was found to be taking place.
Limitations
A significant limitation of the current study is that participants
were initially recruited via an educational event related to
osteoporosis and subsequently recruited through peer net-
works. As such, most of the participants had an active interest
in the area of osteoporosis and a high degree of expertise
related to the subject. Awareness of reporting errors in this
sample then may not reflect awareness on the part of most
family physicians in Ontario. In fact, it is relatively safe to
assume that any gaps in the knowledge or practices of the
interviewed “experts” would be magnified in a sample of
family physicians from the general population. Similarly, the
interviewed participants were all from urban or suburban
areas. It is unknown whether differences in knowledge and
practice would have been observed between physician partic-
ipants here and those with practices in rural areas.
Nevertheless, this study does suggest there is an ongoing
problem with the way fracture risk assessments are produced
and translated into treatment recommendations. Fracture risk
assessments on BMD reports are often inaccurate as they
depend on clinical information that radiologists may find
difficult to access [5]; obtaining reliable risk factor informa-
tion is time-consuming as is translating this information onto
assessments and treatment recommendations. At the same
time, reimbursement for BMD testing is on the decline inter-
nationally [10, 11] which offers clinicians less incentive to
assume responsibility for risk reporting and the provision of
guideline-driven recommendations. Despite this, obtaining an
accurate fracture risk assessment and corresponding treatment
recommendations, especially for those at high risk, is of
paramount importance to the goal of reducing fractures. The
current situation appears to be one in which some family
physicians are modifying their behaviors in order to fill care
gaps, despite a lack of compensation, duplication of efforts,
and other practical constraints. Better capture of risk informa-
tion on BMD referrals, quality control standards for images,
and standardization of risk reporting may help attenuate some
of this ambiguity and inefficiency.
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